 Aridis Pharmaceuticals, Inc. Nasdaq: ARDS, a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, today announced that Vu Truong, Ph.D., Chief Executive Officer, will participate in Cantor Fitzgeralds Virtual Symposium: Winning Ways to Treat Infections and COVID-19 being held on Tuesday, June 30, 2020. 